Our company mainly engages in pharmaceutical sales, which mainly engaged in product categories such as API, intermediates, medical excipients, basic chemicals and agrochemicals.
(API)Apalutamide; Decitabine; Docetaxel; Erlotinib hydrochloride; Fludarabine Phosphate; Gemcitabine HCL; Medroxyprogesterone Acetate; Palbociclib; Paclitaxel; Irinotecan; Sunitinib malate; Cefotaxime sodium; Faropenem Sodium; Spectinomycin dihydrochloride; Pazufloxacin Mesilat; Vancomycin; Argatroban; Betrixaban; Agomelatine. (Excipient)CROSPOVIDONE XL 10; Ethyl cellulose; Carnitine trisodium; Denatonium Benzoate Anhydrous; HEPES; 1,1,1,2-Tetrafluoroethane; 1,2-Distearoyl-sn-glycero-3-phosphocholine; N-(Isoxazol-5-yl)sulphanilamide; Egg yolk lecithin; Sucrose octaacetate;Span 20. (Basic chemical)2-CHLOROTHIOPHENOL; 2-Methoxyethyl chloride; 2-Methyltetrahydrofuran; 2-naphthol; 3-Chloro-2-methylpropene; 4-(2-methoxyethyl)phenol; 4-Chlorotoluene; 4-Cyanobenzoic acid;6-Aminopenicillanic acid(6APA ; Acetyl acetone; Aloe Emodin; Boric acid; Cysteamine hydrochloride; D(+)-Tryptophan; Diethyl ethoxymethylenemalonate; Dimethyl sulfoxide; Diphenyl Amine; Di-tert-butyl dicarbonate; DL-Tartaric Acid; D-Serine; D-Tartaric acid; Ethyl vanillin. (Agrochemicals)1H, 1,2,4-Triazole; 2,3,5,6-Tetrachloropyridine; 2 - hydrazine - 4 - methyl-benzothiazole(HMBT);2, 4 Dichloro Acetophenone; 2, 6 - Diethyl Aniline.
more >
Year of Establishment:
2000
Total Assets(USD):
choose not to disclose
Total Number of Staff:
150 to 199
Main Competitive Advantages:
Delivery Term,Production capacity,Contract Manufacturing,Buyers Specifications Accepted,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
OEM
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Asia
Other Competitive Advantages:
Patents and Copyrights: